1 / 142

LUNG TRANSPLANTATION

ISHLT. 2010. J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141. LUNG TRANSPLANTATION. Overall. ISHLT. 2010. J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141. NUMBER OF LUNG TRANSPLANTS REPORTED BY YEAR AND PROCEDURE TYPE.

baxter-mcgee
Download Presentation

LUNG TRANSPLANTATION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 LUNG TRANSPLANTATION Overall

  2. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 NUMBER OF LUNG TRANSPLANTS REPORTED BY YEAR AND PROCEDURE TYPE NOTE: This figure includes only the lung transplants that are reported to the ISHLT Transplant Registry. As such, this should not be construed as representing changes in the number of lung transplants performed worldwide.

  3. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 AVERAGE CENTER VOLUMELung Transplants: January 1, 2000 - June 30, 2009

  4. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 DISTRIBUTION OF TRANSPLANTS BY CENTER VOLUMELung Transplants: January 1, 2000 - June 30, 2009

  5. LUNG TRANSPLANTS:Transplant Recipient Age by Year of TransplantTransplants: January 1, 1987 – June 30, 2009 ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141

  6. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 AGE DISTRIBUTION OF LUNG TRANSPLANT RECIPIENTS(1/1985-6/2009)

  7. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 AGE DISTRIBUTION OF LUNG TRANSPLANT RECIPIENTS BY ERA Transplants with unknown recipient age were excluded from this tabulation.

  8. LUNG TRANSPLANTS:Donor Age by Year of TransplantTransplants: January 1, 1987 – June 30, 2009 ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141

  9. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 DONOR AGE DISTRIBUTION FOR LUNG TRANSPLANTS (1/1985-6/2009)

  10. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 DONOR AGE DISTRIBUTION FOR LUNG TRANSPLANTS BY ERA Transplants with unknown donor age were excluded from this tabulation.

  11. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 LUNG TRANSPLANTATION Adult Recipients

  12. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 AGE DISTRIBUTION OF ADULT LUNG TRANSPLANT RECIPIENTS(1/1985-6/2009)

  13. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 AGE DISTRIBUTION OF ADULT LUNG TRANSPLANT RECIPIENTS BY ERA

  14. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 AGE DISTRIBUTION OF ADULT LUNG TRANSPLANT RECIPIENTS BY ERA

  15. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival (Transplants: January 1994 - June 2008)

  16. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATION: Indications(1/1995-6/2009)

  17. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATION: Distribution of Procedure Type for Major Indications(1993-2008)

  18. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONProcedure Type within Indication, by Year

  19. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATION: Indications for Single Lung Transplants (Transplants: January 1995 - June 2009) *Other includes: Sarcoidosis: 2.0% Bronchiectasis: 0.4% Congenital Heart Disease: 0.3% LAM: 0.9% OB (non-ReTx): 0.5% Miscellaneous: 5.3%

  20. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATION: Indications for Bilateral/Double Lung Transplants (Transplants: January 1995 - June 2009) *Other includes: Sarcoidosis: 3.0% Bronchiectasis: 4.4% Congenital Heart Disease: 1.3% LAM: 1.2% OB (non-ReTx): 1.2% Miscellaneous: 5.8%

  21. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONMajor Indications By Year (%)

  22. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONMajor Indications By Year (Number)

  23. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTS:AGE DISTRIBUTION BY LOCATIONTransplants between January 2000 and June 2009

  24. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTS:DIAGNOSIS DISTRIBUTION BY LOCATION Transplants between January 2000 and June 2009

  25. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTS:DONOR AGE DISTRIBUTION BY LOCATIONTransplants between January 2000 and June 2009

  26. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Era (Transplants: January 1988 – June 2008)

  27. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Age Group(Transplants: January 1990 – June 2008)

  28. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Gender(Transplants: January 1990 – June 2008)

  29. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis(Transplants: January 1990 – June 2008)

  30. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis Conditional on Survival to 3 Months(Transplants: January 1990 – June 2008)

  31. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis Conditional on Survival to 1 Year(Transplants: January 1990 – June 2008)

  32. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival for Eisenmenger’s Syndrome(Transplants: January 1990 – June 2008)

  33. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Procedure Type(Transplants: January 1990 – June 2008)Diagnosis: Alpha-1 Antitrypsin Deficiency

  34. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Procedure Type and Age (Transplants: January 1990 – June 2008)Diagnosis: Alpha-1 Antitrypsin Deficiency

  35. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type(Transplants: January 1990 – June 2008) Diagnosis: Emphysema/COPD

  36. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type and Age(Transplants: January 1990 – June 2008) Diagnosis: Emphysema/COPD

  37. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type(Transplants: January 1990 – June 2008)Diagnosis: Idiopathic Pulmonary Fibrosis

  38. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type (Transplants: January 1990 – June 2008)Diagnosis: Idiopathic Arterial Pulmonary Hypertension

  39. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type and Era(Transplants: January 1990 – June 2008) Diagnosis: Emphysema/COPD, Single Lung

  40. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type and Era(Transplants: January 1990 – June 2008) Diagnosis: Emphysema/COPD, Double Lung

  41. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type and Era(Transplants: January 1990 – June 2008) Diagnosis: Idiopathic Pulmonary Fibrosis, Single Lung

  42. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type and Era(Transplants: January 1990 – June 2008) Diagnosis: Idiopathic Pulmonary Fibrosis, Double Lung

  43. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Donor CMV status/Recipient CMV status(Transplants: October 1999 – June 2008)

  44. PERCENTAGE OF ADULT LUNG TRANSPLANT RECIPIENTS Experiencing Rejection between Transplant Discharge and 1-Year Follow-UpStratified by Donor/Recipient CMV status (Follow-ups: July 2004 - June 2009) ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 D(-)/R(-): N = 866 D(-)/R(+): N = 1,106 D(+)/R(-): N = 1,218 D(+)/R(+): N = 1,987 No comparisons were statistically significant at 0.05 Treated rejection = Recipient was reported to (1) have at least one acute rejection episode that was treated with an anti-rejection agent; or (2) have been hospitalized for rejection. No rejection = Recipient had (i) no acute rejection episodes and (ii) was reported either as not hospitalized for rejection or did not receive anti-rejection agents. Analysis is limited to patients who were alive at the time of the follow-up

  45. PERCENTAGE OF ADULT LUNG TRANSPLANT RECIPIENTS Experiencing Rejection between Transplant Discharge and 1-Year Follow-Up Stratified by Donor/Recipient CMV status (Follow-ups: July 2004 - June 2009) ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 18-34 35-49 50-59 60-65 66+ Female Male No comparisons were statistically significant at 0.05 except 50-59: D(+)/R(-) vs. D(+)/R(+) (p=0.0385) Treated rejection = Recipient was reported to (1) have at least one acute rejection episode that was treated with an anti-rejection agent; or (2) have been hospitalized for rejection. No rejection = Recipient had (i) no acute rejection episodes and (ii) was reported either as not hospitalized for rejection or did not receive anti-rejection agents. Analysis is limited to patients who were alive at the time of the follow-up

  46. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTS (1996-6/2008)Risk Factors for 1 Year Mortality Reference group = COPD/Emphysema, Single lung (N=13,079) *Other = All diagnoses other than COPD, IPAH, IPF, cystic fibrosis, pulmonary fibrosis,bronchiectasis,alpha-1 antitrypsin deficiency, retransplant and LAM.

  47. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTS (1996-6/2008)Risk Factors for 1 Year Mortality (N=13,079)

  48. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTS (1996-6/2008) Risk Factors for 1 Year Mortality (N=13,079)

  49. ADULT LUNG TRANSPLANTS (1996-6/2008)Borderline Significant Risk Factors for 1 Year Mortality ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 (N=13,079)

  50. ISHLT 2010 J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141 ADULT LUNG TRANSPLANTS(1/1996-6/2008)Risk Factors for 1 Year Mortality

More Related